Physician profile
Mehak Dhande
NPI 1841606969
$21,005.31
in general payments reported to CMS, 2019-2025
14 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $118 · 2021: $9,013 · 2022: $10K · 2023: $675 · 2024: $535 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $405 · Grant: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $405.09 |
| Grant | $147.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,514.20 | 2021-2024 | Pulseselect |
| Boston Scientific Corporation | $8,749.72 | 2019-2025 | Farapulse, General - Therapies |
| Abbott Laboratories | $686.26 | 2020-2025 | Amplatzer Amulet |
| Biosense Webster, INC. | $481.26 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Astellas Pharma US INC | $198.00 | 2019 | |
| Atricure, INC. | $151.32 | 2022 | |
| Cardiva Medical, INC. | $63.05 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.65 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.10 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $28.95 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $21.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.88 | 2020 | |
| Amgen INC. | $15.00 | 2020 | |
| Chiesi USA, INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehak Dhande listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.